Immunai
immunai.comLocations
New York, NY, USA · Canal Street, New York, NY, USA
industry
Biotechnology
Size
51 - 200 employees
Stage
Series B
founded in
2019
Comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development, and improve patient outcomes.
Is this your company?
If you're responsible for hiring at this company, make sure your company and job information are always up to date to attract top talent from the Israel VC Forum network.
Something looks off?
Open jobs at Immunai
On-site & Remote
Job function
Seniority
Salary
